News Archive: 2023
-
-
FDA Inspectors Flag Issues at Novo Nordisk Semaglutide PlantOctober 2, 2023
-
Philips Agrees to $479 Million Settlement for Recalled CPAP DevicesSeptember 24, 2023
-
Study: Quartz Countertop Manufacturing Linked to SilicosisSeptember 21, 2023
-
Roundup Class-Action Cancer Lawsuit Begins in AustraliaSeptember 20, 2023
-
Government Promises Faster Process for Camp Lejeune Toxic Water ClaimsSeptember 20, 2023
-
PFAS in Water at Military Sites Far Exceeds Allowable LimitsSeptember 14, 2023
-
FDA: Avoid Wegovy, Ozempic During PregnancySeptember 7, 2023
-
Direct Connection Found Between Forever Chemicals and Testicular CancerSeptember 5, 2023
Who Am I Calling?
Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617